Table of Contents for the Digital Edition of Pharmacy & Therapeutics - September 2010 Pharmacy & Therapeutics - September 2010 Contents Editorial Medication Errors Prescription: Washington New Drugs/Drug News/New Medical Devices Drug Forecast An Update on Activated Protein C (Xigris) In the Management of Sepsis Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States American Diabetes Association Pharmaceutical Approval Update Product Profiler: VimovoTM Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) Pharmacy & Therapeutics - September 2010 Pharmacy & Therapeutics - September 2010 - Pharmacy & Therapeutics - September 2010 (Page Cover1) Pharmacy & Therapeutics - September 2010 - Contents (Page Cover2) Pharmacy & Therapeutics - September 2010 - Contents (Page 479) Pharmacy & Therapeutics - September 2010 - Contents (Page 480) Pharmacy & Therapeutics - September 2010 - Contents (Page 481) Pharmacy & Therapeutics - September 2010 - Contents (Page 482) Pharmacy & Therapeutics - September 2010 - Contents (Page 483) Pharmacy & Therapeutics - September 2010 - Contents (Page 484) Pharmacy & Therapeutics - September 2010 - Editorial (Page 485) Pharmacy & Therapeutics - September 2010 - Medication Errors (Page 486) Pharmacy & Therapeutics - September 2010 - Medication Errors (Page 487) Pharmacy & Therapeutics - September 2010 - Medication Errors (Page 488) Pharmacy & Therapeutics - September 2010 - Medication Errors (Page 489) Pharmacy & Therapeutics - September 2010 - Prescription: Washington (Page 490) Pharmacy & Therapeutics - September 2010 - Prescription: Washington (Page 491) Pharmacy & Therapeutics - September 2010 - New Drugs/Drug News/New Medical Devices (Page 492) Pharmacy & Therapeutics - September 2010 - New Drugs/Drug News/New Medical Devices (Page 493) Pharmacy & Therapeutics - September 2010 - New Drugs/Drug News/New Medical Devices (Page 494) Pharmacy & Therapeutics - September 2010 - New Drugs/Drug News/New Medical Devices (Page 495) Pharmacy & Therapeutics - September 2010 - New Drugs/Drug News/New Medical Devices (Page 496) Pharmacy & Therapeutics - September 2010 - New Drugs/Drug News/New Medical Devices (Page 497) Pharmacy & Therapeutics - September 2010 - Drug Forecast (Page 498) Pharmacy & Therapeutics - September 2010 - Drug Forecast (Page 499) Pharmacy & Therapeutics - September 2010 - Drug Forecast (Page 500) Pharmacy & Therapeutics - September 2010 - Drug Forecast (Page 501) Pharmacy & Therapeutics - September 2010 - Drug Forecast (Page 502) Pharmacy & Therapeutics - September 2010 - Drug Forecast (Page 503) Pharmacy & Therapeutics - September 2010 - An Update on Activated Protein C (Xigris) In the Management of Sepsis (Page 504) Pharmacy & Therapeutics - September 2010 - An Update on Activated Protein C (Xigris) In the Management of Sepsis (Page 505) Pharmacy & Therapeutics - September 2010 - An Update on Activated Protein C (Xigris) In the Management of Sepsis (Page 506) Pharmacy & Therapeutics - September 2010 - An Update on Activated Protein C (Xigris) In the Management of Sepsis (Page 507) Pharmacy & Therapeutics - September 2010 - An Update on Activated Protein C (Xigris) In the Management of Sepsis (Page 508) Pharmacy & Therapeutics - September 2010 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes (Page 509) Pharmacy & Therapeutics - September 2010 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes (Page 510) Pharmacy & Therapeutics - September 2010 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes (Page 511) Pharmacy & Therapeutics - September 2010 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes (Page 512) Pharmacy & Therapeutics - September 2010 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes (Page 513) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 514) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 515) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 516) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 517) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 518) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 519) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 520) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 521) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 522) Pharmacy & Therapeutics - September 2010 - Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States (Page 523) Pharmacy & Therapeutics - September 2010 - American Diabetes Association (Page 524) Pharmacy & Therapeutics - September 2010 - American Diabetes Association (Page 525) Pharmacy & Therapeutics - September 2010 - Pharmaceutical Approval Update (Page 526) Pharmacy & Therapeutics - September 2010 - Pharmaceutical Approval Update (Page 527) Pharmacy & Therapeutics - September 2010 - Pharmaceutical Approval Update (Page 528) Pharmacy & Therapeutics - September 2010 - Pharmaceutical Approval Update (Page 529) Pharmacy & Therapeutics - September 2010 - Pharmaceutical Approval Update (Page Cover4) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page VCover1) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page VCover2) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V1) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V2) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V3) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V4) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V5) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V6) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V7) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V8) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V9) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V10) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V11) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V12) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V13) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V14) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V15) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V16) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V17) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V18) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V19) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V20) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V21) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V22) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V23) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V24) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V25) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V26) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V27) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V28) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V29) Pharmacy & Therapeutics - September 2010 - Product Profiler: VimovoTM (Page V30) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page HCover1) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page HCover2) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H1) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H2) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H3) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H4) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H5) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H6) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H7) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H8) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H9) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H10) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H11) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H12) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H13) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H14) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H15) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H16) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H17) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H18) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H19) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H20) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H21) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H22) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H23) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H24) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H25) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H26) Pharmacy & Therapeutics - September 2010 - Product Profiler: Helixate® FS Antihemophilic Facor (Recombinant) (Page H27) http://www.nxtbook.com/nxtbooks/medimedia/pt_201306 http://www.nxtbook.com/nxtbooks/medimedia/pt_201305 http://www.nxtbook.com/nxtbooks/medimedia/pt_201304 http://www.nxtbook.com/nxtbooks/medimedia/pt_201303 http://www.nxtbook.com/nxtbooks/medimedia/pt_201302 http://www.nxtbook.com/nxtbooks/medimedia/pt_201301 http://www.nxtbook.com/nxtbooks/medimedia/pt_201212 http://www.nxtbook.com/nxtbooks/medimedia/pt_201211 http://www.nxtbook.com/nxtbooks/medimedia/pt_201210 http://www.nxtbook.com/nxtbooks/medimedia/pt_201209 http://www.nxtbook.com/nxtbooks/medimedia/pt_201208 http://www.nxtbook.com/nxtbooks/medimedia/pt_201207 http://www.nxtbook.com/nxtbooks/medimedia/pt_201206 http://www.nxtbook.com/nxtbooks/medimedia/pt_201205 http://www.nxtbook.com/nxtbooks/medimedia/pt_dexilantprofiler http://www.nxtbook.com/nxtbooks/medimedia/pt_201204 http://www.nxtbook.com/nxtbooks/medimedia/pt_201203 http://www.nxtbook.com/nxtbooks/medimedia/pt_201202 http://www.nxtbook.com/nxtbooks/medimedia/pt_201201 http://www.nxtbook.com/nxtbooks/medimedia/pt_201112 http://www.nxtbook.com/nxtbooks/medimedia/pt_201111 http://www.nxtbook.com/nxtbooks/medimedia/pt_201110 http://www.nxtbook.com/nxtbooks/medimedia/pt_201109 http://www.nxtbook.com/nxtbooks/medimedia/pt_201108 http://www.nxtbook.com/nxtbooks/medimedia/pt_201107 http://www.nxtbook.com/nxtbooks/medimedia/pt_201106 http://www.nxtbook.com/nxtbooks/medimedia/pt_201105 http://www.nxtbook.com/nxtbooks/medimedia/pt_201104 http://www.nxtbook.com/nxtbooks/medimedia/pt_201103 http://www.nxtbook.com/nxtbooks/medimedia/pt_201102 http://www.nxtbook.com/nxtbooks/medimedia/pt_201101 http://www.nxtbook.com/nxtbooks/medimedia/pt_201012 http://www.nxtbook.com/nxtbooks/medimedia/pt_201011 http://www.nxtbook.com/nxtbooks/medimedia/pt_201010 http://www.nxtbook.com/nxtbooks/medimedia/pt_201009 http://www.nxtbook.com/nxtbooks/medimedia/pt_201008 http://www.nxtbook.com/nxtbooks/medimedia/pt_201007 http://www.nxtbook.com/nxtbooks/medimedia/pt_201006 http://www.nxtbook.com/nxtbooks/medimedia/pt_201005 http://www.nxtbook.com/nxtbooks/medimedia/pt_201004 http://www.nxtbook.com/nxtbooks/medimedia/pt_201003 http://www.nxtbook.com/nxtbooks/medimedia/pt_201002 http://www.nxtbook.com/nxtbooks/medimedia/pt_201001 http://www.nxtbook.com/nxtbooks/medimedia/pt_200912 http://www.nxtbook.com/nxtbooks/medimedia/pt_200911 http://www.nxtbook.com/nxtbooks/medimedia/pt_200910 http://www.nxtbook.com/nxtbooks/medimedia/pt_200909 http://www.nxtbook.com/nxtbooks/medimedia/pt_200908 http://www.nxtbook.com/nxtbooks/medimedia/pt_200907 http://www.nxtbook.com/nxtbooks/medimedia/pt_200906 http://www.nxtbook.com/nxtbooks/medimedia/pt_200905 http://www.nxtbook.com/nxtbooks/medimedia/pt_200904 http://www.nxtbook.com/nxtbooks/medimedia/pt_200903 http://www.nxtbook.com/nxtbooks/medimedia/pt_200902 http://www.nxtbook.com/nxtbooks/medimedia/pt_200901 http://www.nxtbook.com/nxtbooks/medimedia/pt_200812 http://www.nxtbook.com/nxtbooks/medimedia/pt_200811 http://www.nxtbook.com/nxtbooks/medimedia/pt_200810 http://www.nxtbook.com/nxtbooks/medimedia/pt_200809 http://www.nxtbook.com/nxtbooks/medimedia/pt_200808 http://www.nxtbook.com/nxtbooks/medimedia/pt_200807 http://www.nxtbook.com/nxtbooks/medimedia/pt_200806 http://www.nxtbook.com/nxtbooks/medimedia/pt_200805 http://www.nxtbook.com/nxtbooks/medimedia/pt_200804 http://www.nxtbook.com/nxtbooks/medimedia/pt_200803 http://www.nxtbook.com/nxtbooks/medimedia/pt_200802 http://www.nxtbook.com/nxtbooks/medimedia/pt_200801 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.